149 related articles for article (PubMed ID: 36979364)
21. Detection of Circulating Tumor Cell-Related Markers in Gynecologic Cancer Using Microfluidic Devices: A Pilot Study.
Law KS; Huang CE; Chen SW
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768623
[TBL] [Abstract][Full Text] [Related]
22. Post-debulking circulating tumor cell as a poor prognostic marker in advanced stage ovarian cancer: A prospective observational study.
Kim M; Suh DH; Choi JY; Bu J; Kang YT; Kim K; No JH; Kim YB; Cho YH
Medicine (Baltimore); 2019 May; 98(20):e15354. PubMed ID: 31096435
[TBL] [Abstract][Full Text] [Related]
23. Detection of circulating tumor cells in drainage venous blood from colorectal cancer patients using a new filtration and cytology-based automated platform.
Tsutsuyama M; Nakanishi H; Yoshimura M; Oshiro T; Kinoshita T; Komori K; Shimizu Y; Ichinosawa Y; Kinuta S; Wajima K; Sakakibara Y; Yatabe Y; Ito S; Kodera Y
PLoS One; 2019; 14(2):e0212221. PubMed ID: 30811434
[TBL] [Abstract][Full Text] [Related]
24. RNA-Seq of Circulating Tumor Cells in Stage II-III Breast Cancer.
Lang JE; Ring A; Porras T; Kaur P; Forte VA; Mineyev N; Tripathy D; Press MF; Campo D
Ann Surg Oncol; 2018 Aug; 25(8):2261-2270. PubMed ID: 29868978
[TBL] [Abstract][Full Text] [Related]
25. Pulmonary venous blood sampling significantly increases the yield of circulating tumor cells in early-stage lung cancer.
Reddy RM; Murlidhar V; Zhao L; Grabauskiene S; Zhang Z; Ramnath N; Lin J; Chang AC; Carrott P; Lynch W; Orringer MB; Beer DG; Nagrath S
J Thorac Cardiovasc Surg; 2016 Mar; 151(3):852-858. PubMed ID: 26614417
[TBL] [Abstract][Full Text] [Related]
26. Circulating Tumor Cells and Transforming Growth Factor Beta in Resected Pancreatic Adenocarcinoma.
Vicente D; Lee AJ; Hall CS; Lucci A; Lee JE; Kim MP; Katz MHG; Hurd MW; Maitra A; Rhim Md AD; Tzeng CD
J Surg Res; 2019 Nov; 243():90-99. PubMed ID: 31170555
[TBL] [Abstract][Full Text] [Related]
27. Size-based isolation of circulating tumor cells in lung cancer patients using a microcavity array system.
Hosokawa M; Kenmotsu H; Koh Y; Yoshino T; Yoshikawa T; Naito T; Takahashi T; Murakami H; Nakamura Y; Tsuya A; Shukuya T; Ono A; Akamatsu H; Watanabe R; Ono S; Mori K; Kanbara H; Yamaguchi K; Tanaka T; Matsunaga T; Yamamoto N
PLoS One; 2013; 8(6):e67466. PubMed ID: 23840710
[TBL] [Abstract][Full Text] [Related]
28. Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients.
Pestrin M; Salvianti F; Galardi F; De Luca F; Turner N; Malorni L; Pazzagli M; Di Leo A; Pinzani P
Mol Oncol; 2015 Apr; 9(4):749-57. PubMed ID: 25539732
[TBL] [Abstract][Full Text] [Related]
29. Clinical application of liquid biopsy in endometrial carcinoma.
Shen Y; Shi R; Zhao R; Wang H
Med Oncol; 2023 Feb; 40(3):92. PubMed ID: 36757457
[TBL] [Abstract][Full Text] [Related]
30. Absence of HER2 Expression of Circulating Tumor Cells in Patients with Non-Metastatic Esophageal Cancer.
Woestemeier A; Ghadban T; Riethdorf S; Harms-Effenberger K; Konczalla L; Uzunoglu FG; Izbicki JR; Pantel K; Bockhorn M; Reeh M
Anticancer Res; 2018 Oct; 38(10):5665-5669. PubMed ID: 30275185
[TBL] [Abstract][Full Text] [Related]
31. Circulating Tumor Cells Identify Early Recurrence in Patients with Non-Small Cell Lung Cancer Undergoing Radical Resection.
Bayarri-Lara C; Ortega FG; Cueto Ladrón de Guevara A; Puche JL; Ruiz Zafra J; de Miguel-Pérez D; Ramos AS; Giraldo-Ospina CF; Navajas Gómez JA; Delgado-Rodriguez M; Lorente JA; Serrano MJ
PLoS One; 2016; 11(2):e0148659. PubMed ID: 26913536
[TBL] [Abstract][Full Text] [Related]
32. Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patients.
Huebner H; Fasching PA; Gumbrecht W; Jud S; Rauh C; Matzas M; Paulicka P; Friedrich K; Lux MP; Volz B; Gass P; Häberle L; Meier-Stiegen F; Hartkopf A; Neubauer H; Almstedt K; Beckmann MW; Fehm TN; Ruebner M
BMC Cancer; 2018 Feb; 18(1):204. PubMed ID: 29463222
[TBL] [Abstract][Full Text] [Related]
33. mRNA expression profiles in circulating tumor cells of metastatic colorectal cancer patients.
Mostert B; Sieuwerts AM; Bolt-de Vries J; Kraan J; Lalmahomed Z; van Galen A; van der Spoel P; de Weerd V; Ramírez-Moreno R; Smid M; Verhoef C; IJzermans JN; Gratama JW; Sleijfer S; Foekens JA; Martens JW
Mol Oncol; 2015 Apr; 9(4):920-32. PubMed ID: 25655581
[TBL] [Abstract][Full Text] [Related]
34. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.
Krebs MG; Hou JM; Sloane R; Lancashire L; Priest L; Nonaka D; Ward TH; Backen A; Clack G; Hughes A; Ranson M; Blackhall FH; Dive C
J Thorac Oncol; 2012 Feb; 7(2):306-15. PubMed ID: 22173704
[TBL] [Abstract][Full Text] [Related]
35. Improved Circulating Tumor Cell Detection by a Combined EpCAM and MCAM CellSearch Enrichment Approach in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy.
Onstenk W; Kraan J; Mostert B; Timmermans MM; Charehbili A; Smit VT; Kroep JR; Nortier JW; van de Ven S; Heijns JB; Kessels LW; van Laarhoven HW; Bos MM; van de Velde CJ; Gratama JW; Sieuwerts AM; Martens JW; Foekens JA; Sleijfer S
Mol Cancer Ther; 2015 Mar; 14(3):821-7. PubMed ID: 25552367
[TBL] [Abstract][Full Text] [Related]
36. Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort.
Jansson S; Bendahl PO; Larsson AM; Aaltonen KE; Rydén L
BMC Cancer; 2016 Jul; 16():433. PubMed ID: 27390845
[TBL] [Abstract][Full Text] [Related]
37. A novel approach using telomerase-specific replication-selective adenovirus for detection of circulating tumor cells in breast cancer patients.
Kim SJ; Masago A; Tamaki Y; Akazawa K; Tsukamoto F; Sato J; Ozawa T; Tsujino Y; Noguchi S
Breast Cancer Res Treat; 2011 Aug; 128(3):765-73. PubMed ID: 21630023
[TBL] [Abstract][Full Text] [Related]
38. Predictive value of circulating tumor cells (CTCs) in newly-diagnosed and recurrent ovarian cancer patients.
Liu JF; Kindelberger D; Doyle C; Lowe A; Barry WT; Matulonis UA
Gynecol Oncol; 2013 Nov; 131(2):352-6. PubMed ID: 23954902
[TBL] [Abstract][Full Text] [Related]
39. Detection of HER2-positive Circulating Tumor Cells Using the LiquidBiopsy System in Breast Cancer.
Chen W; Zhang J; Huang L; Chen L; Zhou Y; Tang D; Xie Y; Wang H; Huang C
Clin Breast Cancer; 2019 Feb; 19(1):e239-e246. PubMed ID: 30472074
[TBL] [Abstract][Full Text] [Related]
40. Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer.
Davis AA; Zhang Q; Gerratana L; Shah AN; Zhan Y; Qiang W; Finkelman BS; Flaum L; Behdad A; Gradishar WJ; Platanias LC; Cristofanilli M
Breast Cancer Res; 2019 Dec; 21(1):137. PubMed ID: 31801599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]